Pearlie P Chong1, Robert L Atmar2,3. 1. Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas. 2. Department of Medicine. 3. Department of Molecular Virology & Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Abstract
PURPOSE OF REVIEW: The majority of norovirus outbreaks in the United States occur in healthcare facilities. With the growing population of immunocompromised hosts who are in frequent contact with healthcare facilities, norovirus is not only a threat to hospitals and nursing homes but also to these individuals. This review summarizes the impact of norovirus infection on healthcare facilities and immunocompromised hosts. RECENT FINDINGS: The natural history of norovirus infection in immunocompromised individuals remains poorly understood. Although host immune responses play a critical role in reducing duration of viral shedding and viral load in norovirus-infected individuals, why some immunocompromised patients spontaneously recover while others develop a chronic and protracted course of illness remains unclear. Norovirus outbreaks occur in healthcare facilities because the virus is highly contagious, resistant to disinfection and efficiently transmitted. The use of real-time metagenomic next-generation sequencing and phylogenetic analyses has provided valuable information on transmission patterns in complex hospital-associated norovirus outbreaks. The development of human intestinal enteroid cultures enables the determination of effectiveness of disinfectants against human noroviruses, circumventing the validity questions with surrogate virus models due to differences in susceptibility to inactivation and disinfectants. SUMMARY: Metagenomics next-generation sequencing can enhance our understanding of norovirus transmission and lead to more timely mitigation strategies to curb norovirus outbreaks in healthcare facilities. With new in-vitro cultivation methods for human noroviruses, candidate vaccines and effective antivirals could be available in the near future.
PURPOSE OF REVIEW: The majority of norovirus outbreaks in the United States occur in healthcare facilities. With the growing population of immunocompromised hosts who are in frequent contact with healthcare facilities, norovirus is not only a threat to hospitals and nursing homes but also to these individuals. This review summarizes the impact of norovirus infection on healthcare facilities and immunocompromised hosts. RECENT FINDINGS: The natural history of norovirus infection in immunocompromised individuals remains poorly understood. Although host immune responses play a critical role in reducing duration of viral shedding and viral load in norovirus-infected individuals, why some immunocompromised patients spontaneously recover while others develop a chronic and protracted course of illness remains unclear. Norovirus outbreaks occur in healthcare facilities because the virus is highly contagious, resistant to disinfection and efficiently transmitted. The use of real-time metagenomic next-generation sequencing and phylogenetic analyses has provided valuable information on transmission patterns in complex hospital-associated norovirus outbreaks. The development of human intestinal enteroid cultures enables the determination of effectiveness of disinfectants against human noroviruses, circumventing the validity questions with surrogate virus models due to differences in susceptibility to inactivation and disinfectants. SUMMARY: Metagenomics next-generation sequencing can enhance our understanding of norovirus transmission and lead to more timely mitigation strategies to curb norovirus outbreaks in healthcare facilities. With new in-vitro cultivation methods for human noroviruses, candidate vaccines and effective antivirals could be available in the near future.
Authors: J Joukje Siebenga; Harry Vennema; Du-Ping Zheng; Jan Vinjé; Bonita E Lee; Xiao-Li Pang; Eric C M Ho; Wilina Lim; Avinash Choudekar; Shobha Broor; Tamar Halperin; Nassar B G Rasool; Joanne Hewitt; Gail E Greening; Miao Jin; Zhao-Jun Duan; Yalda Lucero; Miguel O'Ryan; Marina Hoehne; Eckart Schreier; Rodney M Ratcliff; Peter A White; Nobuhiro Iritani; Gábor Reuter; Marion Koopmans Journal: J Infect Dis Date: 2009-09-01 Impact factor: 5.226
Authors: Eyal Leshem; Mary Wikswo; Leslie Barclay; Eric Brandt; William Storm; Ellen Salehi; Traci DeSalvo; Tim Davis; Amy Saupe; Ginette Dobbins; Hillary A Booth; Christianne Biggs; Katie Garman; Amy M Woron; Umesh D Parashar; Jan Vinjé; Aron J Hall Journal: Emerg Infect Dis Date: 2013-08 Impact factor: 6.883
Authors: Robert L Atmar; Antone R Opekun; Mark A Gilger; Mary K Estes; Sue E Crawford; Frederick H Neill; David Y Graham Journal: Emerg Infect Dis Date: 2008-10 Impact factor: 6.883
Authors: Amy Davis; Valerie Cortez; Marco Grodzki; Ronald Dallas; Jose Ferrolino; Pamela Freiden; Gabriela Maron; Hana Hakim; Randall T Hayden; Li Tang; Adam Huys; Abimbola O Kolawole; Christiane E Wobus; Melissa K Jones; Stephanie M Karst; Stacey Schultz-Cherry Journal: Viruses Date: 2020-06-05 Impact factor: 5.048